British Oncology brings three world-leading technologies together under one roof — providing the complete cancer care pathway from diagnosis through to treatment and follow-up.
State-of-the-art Positron Emission Tomography combined with CT scanning — the global gold standard for oncology staging, restaging and treatment response assessment. Our PET-CT service will be a first-access resource for referring hospitals across the Gulf.
Our Akesis Gemini360RT® Linear Accelerator — FDA 510(k) cleared and among the most advanced LINAC platforms available — delivers IMRT, VMAT, SBRT and SRS with sub-millimetre precision. Online adaptive radiotherapy ensures the plan is re-optimised for each patient's daily anatomy.
The first GammaPod in the Middle East, GCC and Africa. Stereotactic breast radiosurgery in 1–3 fractions, with zero skin dose, minimal heart and lung exposure, and sub-millimetre precision. A transformative option for early-stage breast cancer patients.
Comprehensive diagnostic pathway including mammography, breast ultrasound, MRI, CT and specialist biopsy services — enabling complete staging and treatment planning within the British Oncology centre.
All complex cases are reviewed by our multidisciplinary oncology team — ensuring every patient benefits from expert collective decision-making before treatment begins. Regional hospitals are invited to present cases to our MDT via secure video link.
A dedicated international patient team manages every aspect of the journey for patients travelling from across the region — including visa support, accommodation, insurance liaison, translation and remote follow-up coordination.